Get started
GBLX CURE ETF UNITSGBLX CURE ETF UNITSGBLX CURE ETF UNITS

GBLX CURE ETF UNITS

No trades
See on Supercharts
Overview Analysis
Holdings
News Discussions Technicals Seasonals

GBLX CURE ETF UNITS holdings


As of April 3, 2025
Symbol
Weight %
Shares
Shares Chg %
1M
Market value
Market value Chg %
1M
A
ALNYAlnylam Pharmaceuticals, Inc
2.91%
‪‪2.08 K‬‬
+1.37%
‪‪854.19 K‬‬AUD
+6.90%
U
UTHRUnited Therapeutics Corporation
2.69%
‪‪1.64 K‬‬
+14.06%
‪‪790.65 K‬‬AUD
+10.77%
A
AMGNAmgen Inc.
2.66%
‪‪1.61 K‬‬
−15.31%
‪‪782.95 K‬‬AUD
−17.28%
I
INSMInsmed Incorporated
2.66%
‪‪6.80 K‬‬
−3.09%
‪‪782.27 K‬‬AUD
−8.75%
G
GILDGilead Sciences, Inc.
2.65%
‪‪4.42 K‬‬
−21.64%
‪‪778.78 K‬‬AUD
−25.62%
V
VRTXVertex Pharmaceuticals Incorporated
2.63%
‪‪1.02 K‬‬
−8.55%
‪‪771.80 K‬‬AUD
−10.29%
N
NTRANatera, Inc.
2.58%
‪‪3.48 K‬‬
+11.82%
‪‪758.04 K‬‬AUD
+6.17%
E
EXASExact Sciences Corporation
2.57%
‪‪10.86 K‬‬
+31.94%
‪‪754.53 K‬‬AUD
+20.36%
A
ABBVAbbVie, Inc.
2.55%
‪‪2.37 K‬‬
−20.50%
‪‪750.99 K‬‬AUD
−25.75%
N
NBIXNeurocrine Biosciences, Inc.
2.53%
‪‪4.61 K‬‬
+13.67%
‪‪745.02 K‬‬AUD
+0.07%
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.